Senate FDA reform hearings scheduled for Feb. 21-22 in Labor & Human Resources Cmte..
This article was originally published in The Rose Sheet
Executive Summary
SENATE FDA REFORM HEARINGS SCHEDULED FOR FEB. 21-22 in the Labor & Human Resources Committee as the panel prepares for a mid-March mark-up of Sen. Nancy Kassebaum's (R-KS) FDA reform bill (S 1477). Hearings will focus on the agency's review process, among other things. FDA reform appears to be hinging on the moderate Kassebaum bill, which is best situated to pass in a shortened election-year session.